AI assistant
Sending…
PRECISION BIOSCIENCES INC — Director's Dealing 2021
Apr 30, 2021
34491_dirs_2021-04-30_18391ead-4f26-48b1-8731-84ee0ce86083.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2021-04-26
Reporting Person: List Alan (Chief Medical Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $6.45 | 2030-10-26 | Common Stock (100000) | Direct |
Footnotes
F1: The option vests in equal 6.25% installments at the end of each three-month period over a 48-month period beginning August 31, 2020.
More from PRECISION BIOSCIENCES INC
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8
Regulatory Filings
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19